Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidder

By Syndicated Content Dec 11, 2022 | 2:44 PM

(Reuters) -French health group Sanofi said on Sunday that it no longer intends to make an offer for biotech company Horizon Therapeutics Plc , leaving Amgen Inc as the only remaining bidder.

The Wall Street Journal reported on Sunday that Amgen was in advanced talks to buy Horizon. A deal could be finalised by Monday assuming the talks with Amgen don’t fall apart, the report added.

(Reporting by Kanjyik Ghosh in BengaluruEditing by Peter Graff)

Gilead appoints Sanofi official Dietmar Berger as next chief medical officer

4h ago

Raiders QB Aidan O'Connell, DE Maxx Crosby miss practice

2h ago

Cantor Fitzgerald pays $6.75 million to settle SEC charges over misleading SPAC disclosures

4h ago

Canada proposed $15 billion incentive to boost AI green data centre investment, Globe and Mail reports

4h ago

White House releases strategy to counter anti-Muslim, anti-Arab hate

4h ago

Ex-Marshall leader Charles Huff introduced as Southern Miss coach

3h ago